martes, 6 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· December 16, 2025

Fortinet Delivers Isolated Infrastructure Acceleration for the AI Factory with NVIDIA

View original at finance.yahoo.com
Fortinet Delivers Isolated Infrastructure Acceleration for the AI Factory with NVIDIA Fortinet, Inc. Collaboration integrates firewalling, segmentation, and policy enforcement directly into NVIDIA BlueField-accelerated infrastructure for higher performance, stronger isolation, and simpler operations SUNNYVALE, Calif…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Running FortiGate VM directly on NVIDIA BlueField-3 DPUs extends the model of infrastructure-offloaded services to include advanced security, allowing organizations to enforce firewalling, segmentation and zero-trust policies at line rate without impacting GPU workloads

    80% confidence
  • Integrating FortiGate VM on BlueField-3 DPU gives customers a practical way to keep security aligned with new performance demands by improving isolation, reducing latency, and simplifying consistent policy enforcement

    80% confidence
  • As enterprises are modernizing their data centers to support AI, private cloud and edge applications require much higher throughput than traditional workloads

    80% confidence
  • AI factories demand an entirely new class of secure, accelerated infrastructure

    80% confidence
  • Traditional host-based firewall architectures struggle to keep pace with the demands of AI workloads, edge services, agentic AI-era traffic, and multitenant isolation

    80% confidence

Citado en estos reportajes de Via News

Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com